Investors & Media
we hope you share our vision of new cancer therapies to help those in need. if you have invested in ziopharm, this section will give you the information and insight you need.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company that is seeking to develop and commercialize a diverse portfolio of treatments for people with cancer. Our focus is on the development of both small molecule and DNA therapeutic candidates. The goal is to develop intravenous ("IV") and/or oral forms of administration. We believe this strategy will result in lower-risk and lower-cost development programs with product candidates having a low cost of manufacturing to address changing reimbursement requirements around the world.